- Report
- October 2018
- 450 Pages
Global
From €3383EUR$3,499USD£2,906GBP
- Report
- June 2022
- 663 Pages
Global
From €4786EUR$4,950USD£4,111GBP
- Report
- April 2022
- 120 Pages
Global
From €5752EUR$5,950USD£4,941GBP
- Report
- November 2020
- 175 Pages
Global
From €3079EUR$3,185USD£2,645GBP
€4399EUR$4,550USD£3,778GBP
- Report
- November 2020
- 111 Pages
From €2030EUR$2,100USD£1,744GBP
€2900EUR$3,000USD£2,491GBP
- Report
- August 2020
- 117 Pages
North America
From €2030EUR$2,100USD£1,744GBP
€2900EUR$3,000USD£2,491GBP
- Report
- August 2020
- 117 Pages
Asia Pacific
From €2030EUR$2,100USD£1,744GBP
€2900EUR$3,000USD£2,491GBP
- Report
- August 2020
- 117 Pages
Europe
From €2030EUR$2,100USD£1,744GBP
€2900EUR$3,000USD£2,491GBP
- Report
- June 2020
- 184 Pages
Global
From €3079EUR$3,185USD£2,645GBP
€4399EUR$4,550USD£3,778GBP
- Report
- April 2023
- 112 Pages
Global
From €4592EUR$4,750USD£3,945GBP
- Report
- April 2023
- 120 Pages
Global
From €4592EUR$4,750USD£3,945GBP
- Report
- February 2023
- 100 Pages
Global
From €2659EUR$2,750USD£2,284GBP
- Report
- July 2022
- 100 Pages
Global
From €2659EUR$2,750USD£2,284GBP
- Report
- July 2022
- 100 Pages
Global
From €2659EUR$2,750USD£2,284GBP
- Report
- August 2022
- 135 Pages
Global
From €4302EUR$4,450USD£3,695GBP
- Report
- April 2022
- 122 Pages
Global
From €4302EUR$4,450USD£3,695GBP
- Report
- October 2019
- 112 Pages
Global
From €4302EUR$4,450USD£3,695GBP
- Report
- November 2019
- 144 Pages
Global
From €2417EUR$2,500USD£2,076GBP
- Report
- May 2022
- 255 Pages
Global
From €3480EUR$3,600USD£2,990GBP
- Report
- May 2022
- 106 Pages
Middle East, Africa
From €1450EUR$1,500USD£1,246GBP
The Wearable Injector market is a subset of the Infusions and Injectables market, which includes a variety of medical devices used to deliver drugs, fluids, and other substances directly into a patient's body. Wearable Injectors are a type of infusion device that are designed to be worn on the body, allowing for continuous or periodic drug delivery. These devices are typically used to deliver medications such as insulin, hormones, and antibiotics, and can be used to treat a variety of conditions. Wearable Injectors offer a number of advantages over traditional infusion methods, including improved patient compliance, increased accuracy of drug delivery, and improved safety.
Some of the major players in the Wearable Injector market include Insulet Corporation, Valeritas, Inc., Becton Dickinson and Company, Tandem Diabetes Care, Inc., and Ypsomed AG. Show Less Read more